FKBPL Polyclonal Antibody

Elabscience
Product Code: E-AB-52239
Product Group: Primary Antibodies
Supplier: Elabscience
CodeSizePrice
E-AB-52239-20uL20uL£125.00
Quantity:
E-AB-52239-60uL60uL£172.00
Quantity:
E-AB-52239-120uL120uL£237.00
Quantity:
E-AB-52239-200uL200uL£344.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species:
  • Human
  • Mouse
  • Rat
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry (IHC)
Shipping:
Ice packs
Storage:
Store at -20°C. Avoid freeze / thaw cycles.

Images

1 / 2
Immunohistochemistry of paraffin-embedded Human liver cancer tissue  using FKBPL Polyclonal Antibody at dilution of 1:50(?200)
2 / 2
Immunohistochemistry of paraffin-embedded Human thyroid cancer tissue  using FKBPL Polyclonal Antibody at dilution of 1:50(?200)

Immunohistochemistry of paraffin-embedded Human liver cancer tissue  using FKBPL Polyclonal Antibody at dilution of 1:50(?200)
Immunohistochemistry of paraffin-embedded Human thyroid cancer tissue  using FKBPL Polyclonal Antibody at dilution of 1:50(?200)

Documents

Further Information

Abbreviation:
FKBPL
Background:
FKBPL,also named as DIR1,NG7 and WISp39,has similarity to the immunophilin protein family,which plays a role in immunoregulation and basic cellular processes involving protein folding and trafficking. This protein is thought to have a potential role in the induced radioresistance,probably by increasing the rate of DNA repair in cells exposed to X rays. Also it appears to have some involvement in general stress response in the control of the cell cycle. It regulates p21 protein stability by binding to Hsp90 and p21. Breast cancer cells stably overexpressing FKBPL became dependent on estrogen for their growth and were dramatically more sensitive to the antiestrogens tamoxifen and fulvestrant,whereas FKBPL knockdown reverses this phenotype. FKBPL is an estrogen-inducible gene that acts as a cochaperone in ERα/Hsp90 molecular complexes; furthermore,FKBPL levels may be both a prognostic indicator and determinant of response to endocrine therapy.
Buffer:
PBS with 0.05% NaN3 and 40% Glycerol,pH7.4
Concentration:
1.3 mg/mL
Conjugation:
Unconjugated
Dilution:
IHC 1:30-1:150, ELISA 1:2000-1:10000
Immunogen:
Fusion protein of human FKBPL
Purification method:
Antigen affinity purification
Target Synonym:
DIR1;FK506 binding protein like;FK506-binding protein-like;Fkbpl;FKBPL;NG7;OTTHUMP00000029170;WAF 1/CIP1 stabilizing protein 39;WAF-1/CIP1 stabilizing protein 39;WISP39
UNIProt ID:
Q9UIM3